4/A
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-036202
President and CEO sold 9,930 shares at an average $17.33 ($172,054)
- President and CEO acquired 9,930 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
McCarthy Sean A. · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-09-01 | Exercise or conversion : show line 1 in the form | +9,930 | $0.95 | $9,384 | 14,175 | D |
| 2017-09-01 | Sale : show line 2 in the form | −9,562 | $17.32 | $165,614 | 4,613 | D |
| 2017-09-01 | Sale : show line 3 in the form | −368 | $17.50 | $6,440 | 4,245 | D |
| Open-market sales · 9,930 sh · avg $17.33 · $172,054 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-09-01 | Exercise or conversion : show line 4 in the form Stock Option (right to buy) | −9,930 | 25,043 | D |
Loading xslF345X03/doc1.xml…